Académique Documents
Professionnel Documents
Culture Documents
to grow at a rate of 7% as more people shun chemical products in favour of organic ones.
"During the last decade, the herbal beauty care business has actually driven the growth of the
beauty business in India. The emphasis has been on the spectacular growth of the herbal and
ayurvedic beauty products business," beauty expert Shahnaz Husain told IANS.
She was the first to introduce the concept of ayurvedic cosmetics to the world when she launched
her products way back in 1970.
Today, the Indian cosmetics industry has a plethora of herbal cosmetic brands like Forest
Essentials, Boutique, Himalaya, Blossom Kochhar, VLCC, Dabur and Lotus; and many more are
adding to the list.
The Indian cosmetics market - defined as skin care, hair care, colour cosmetics, fragrances and
oral care segments - stood at an estimated $2.5 billion in 2008 and is expected to grow at seven
per cent, according to an analysis of the sector.
One such brand is Tathaastu, which deals in products made of essential oils.
Divita Kanoria, Tathaastu's chief wellness officer, said the presence of artificial and chemical
ingredients in their cosmetic products has made people rethink about suitable alternatives to suit
their skin.
"Of late, there have been attempts to find alternatives. Beauty recipes from China and India using
traditional herbs have earned a special significance the world over. Ayurvedic recipes from India
for skin and hair treatment also serve as cosmetics," Kanoria said.
"The best part about organic cosmetics is that unlike chemical-based cosmetics, these do not
interfere with the body's absorption of Vitamin D. Moreover, these help an individual to have a
healthy skin, lustrous hair and glowing complexion in a completely natural way," she added.
People have also become aware of the "ingredients" of cosmetic products.
"Today awareness of beauty products and treatments, fashion and grooming is at an all time
high. The Indian customer is very much aware of the ingredients in cosmetic products, the
benefits of plant products and the harmful effects of chemical ingredients," Husain said.
"Also the concept of 'total well being' has steadily gained ground. There is much more awareness
of the wellness concept and its benefits among people today," she added.
Husain recollects how she had to create awareness among people about the benefits of ayurvedic
products when she launched her brand four decades ago.
"Very early in my career, I had to create awareness of the benefits of ayurvedic products and
herbal healing. I made it a point to reply personally to letters seeking solutions for skin and hair
problems," Husain said.
"My philosophy and faith in ayurveda have not only influenced markets and minds but have
become an integral part of my person and brand image," she added.
Ghaziabad, Uttar Pradesh, April 7, 2010 /India PRwire/ -- The Society for New Age Herbals, a
non-profit organization working towards promoting evidence-based herbal medicinal systems in
India, today launched the list of top 20 selling classical Ayurvedic herbal OTC products in India.
This first of its kind list has ranked the age-old immunity builder Chyawanprash is the largest
selling Ayurvedic Herbal OTC product, with Triphala Churna (a mild laxative),
Dashmularishta (female reproductive health normaliser post-delivery), Ashokarishta
(menstrual cycle regulator) and Lavan Bhaskar Churna (digestive) making up the Top 5.
The exhaustive list has been put together on the basis of inputs from leading Ayurvedic
companies and discussions with practicing Vaidyas. "The Society has been feeling the need of
coming out with this list in view of the strong growth that Ayurvedic medicines have been
witnessing in the recent years. No concerted efforts have so far being made in India to conduct a
systematic study to find out top 20 selling classical Ayurvedic herbal OTC products. We have,
for the first time, undertaken this task," said Mr. C.P. Khare, a renowned international author of
several reference works on herbal medicines and founder President of the Society Society for
New Age Herbals.
The current market of Ayurvedic, Unani & Siddha medicines in India is estimated to be about
Rs. 8,000 crores, out of which the estimated share of classical AYUSH medicines is estimated to
be about Rs. 500 crores. Ayurvedic medicines are normally made from raw materials of herbal,
mineral, metal, marine as well as animal origin. However, for this particular exercise only those
classical Ayurvedic products with herbal ingredients have been evaluated in order to keep pace
with the International trend. The scope of this study included only classical, herbal, OTC
products. The exclusions from the study include metallic, herbometallic and mineral products,
though they enjoy a good market share.
The market scenario of Ayurvedic products is quite complex and this report should be considered
as a small but significant initiative of the Society for New Age Herbals to create competitiveness
leading to the growth of AYUSH products, said Mr. Khare. "Countries like US keep declaring
the list of top 20 selling herbal products which acts as a stimulus to the market. No such exercise
has ever been done in India since the major market research agencies do not cover AYUSH
products for market size estimations. Coming out with the list of top 20 selling classical
Ayurvedic Herbal OTC products in India is one of the major initiatives of the Society for New
Age Herbals and is likely to act as a trend setter," he added.
Notes to Editor
The society, which works towards bridging the gap between ancient wisdom and scientific
advancements, also brings out a bi-monthly bulletin besides organizing quarterly meetings to
review and discuss the current researches going on in the field of herbal medicines.
The Governing body of the Society includes eminent persons across the relevant scientific
disciplines: Dr.V.K. Agarwal (Clinical Pharmacology), Mrs. Santosh Mehtani (Botany &
Pharmacognosy), Dr. Prem Kishore (Clinical Practice & Ayurvedic Research), Dr. Mayaram
Uniyal (Pharmacognosy), Dr. Brahma Singh (Pharmacognosy & Herbal Plantation), Dr. K.K.
Srivastava (Clinical Biochemistry, Adaptive Medicine), Dr. Gian Singh (Phytopharmacology),
Dr. C.K. Katiyar (Ayurvedic Drug Research), Prof. (Dr.) V.V. Prasad (Clinical Practice &
Ayurvedic Research), Dr. Rajendra Gupta (Pharmacognosy & Herbal Plantation), Prof.(Hakeem)
Anwar Ahmad (Clinical Practice & Unani Research), Dr. Navin Kr. Sharma (Herbal Drug
Development), Dr. (Mrs.) R.D. Kak (Botany & Pharmacognosy), Mrs. Parmod Singla (Botany &
Pharmacognosy), Dr. Rekha Sharda (Phytochemistry), Dr. Deepika Gunawant (Global Herbal
Regulations).
by Subhuti Dharmananda, Ph.D., Director, Institute for Traditional Medicine, Portland, Oregon
Ayurvedic medicines are produced by several thousand companies in India, but most of them are
quite small, including numerous neighborhood pharmacies that compound ingredients to make
their own remedies. It is estimated that the total value of products from the entire Ayurvedic
production in India is on the order of one billion dollars (U.S.). The industry has been dominated
by less than a dozen major companies for decades, joined recently by a few others that have
followed their lead, so that there are today 30 companies doing a million dollars or more per year
in business to meet the growing demand for Ayurvedic medicine. The products of these
companies are included within the broad category of "fast moving consumer goods" (FMCG;
which mainly involves foods, beverages, toiletries, cigarettes, etc.). Most of the larger Ayurvedic
medicine suppliers provide materials other than Ayurvedic internal medicines, particularly in the
areas of foods and toiletries (soap, toothpaste, shampoo, etc.), where there may be some overlap
with Ayurveda, such as having traditional herbal ingredients in the composition of toiletries.
The key suppliers in Ayurveda are Dabur, Baidyanath, and Zandu, which together have about
85% of India's domestic market. These and a handful of other companies are mentioned
repeatedly by various writers about the Ayurvedic business in India; a brief description is
provided for them, arranged here from oldest to newest:
Dabur India Ltd. is India's largest Ayurvedic medicine
supplier and the fourth largest producer of FMCG. It was
established in 1884, and had grown to a business level in
2003 of about 650 million dollars per year, though only a
fraction of that is involved with Ayurvedic medicine. Last
year, about 15% of sales volume was pharmaceuticals, the
remaining 85% were mostly non-medicine items such as
foods and cosmetics. Dabur's Ayurvedic Specialities
Division has over 260 medicines for treating a range of
ailments and body conditions-from common cold to
chronic paralysis. These materials constitute only 7% of
Dabur's total revenue (thus, less than 50 million dollars).
Dabur Chyawanprash (herbal honey) has a market share of
70% and chewable Hajmola Digestive Tablets has an 88%
share. Other major products are Dabur Amla Hair Oil,
Vatika (Shampoo), and Lal Dant Manjan (Tooth Powder).
Sri Baidyanath Ayurvedic Bhawan Ltd. (Baidyanath for
short) was founded in 1917 in Calcutta, and specializes in
Ayurvedic medicines, though it has recently expanded into
the FMCG sector with cosmetic and hair care products;
one of its international products is Shikakai (soap pod)
Shampoo. Baidyanath has a sales volume of about 350
million dollars, but most of the product sales are in the
cosmetic range. The company reports having over 700
Ayurvedic products, made at 10 manufacturing centers,
with 1,600 employees. Included items are herbal teas,
patent medicines, massage oils, and chyawanprash.
Zandu Pharmaceutical Works was incorporated in Bombay
in 1919, named after an 18th-century Ayurvedic. The
company focuses primarily on Ayurvedic products (in
1930, pharmaceuticals were added, but the pharmaceutical
division was separated off about 30 years later). However,
today Zandu has a chemicals division and cosmetics
division. Its total sales volume is about 45 million dollars.
One of its current projects is to develop a dopamine drug
from a plant extract, applying for new drug status in the
U.S.
The Himalaya Drug Company was established in 1934 in
Bangalore. It currently has a business level of about 500
million dollars and has a U.S. distribution division
(Himalaya USA). It is known in the U.S. for the product
Liv-52, marketed as a liver protector and therapy for liver
diseases like viral hepatitis; the product was first marketed
in India in 1955.
Charak Pharmaceuticals was founded in 1947, and
currently has three distribution centers in India; it produces
liquids, tablets, and veterinary supplies. It has gained a
large advantage with its new product Evanova, a
preparation containing 33 herbs and minerals and non-
hormonal active ingredients used as a menopause treatment
alternative to HRT. Soya is one of the main ingredients in
this product. The product also contains Ayurvedic herbs
that act like selective estrogen receptor modulators as well
as asparagus root (shatavari), which reduces the frequency
and intensity of hot flashes.
Vicco Laboratories was established in 1958. It mainly
produces topical therapies based on Ayurveda and is best
known internationally for its toothpaste product,
Vajradanti, which has been marketed in the U.S. for more
than 25 years.
The Emami Group, founded in 1974, provides a diverse
range of products, doing 110 million dollars of business
annually, though only a portion is involved with Ayurvedic
products, through its Himani line; the company is mainly
involved with toiletries and cosmetics, but also provides
Chyawanprash and other health products.
Aimil Pharmaceuticals Ltd., incorporated in 1984 and
engaged in manufacturing and sale of both generic and
proprietary Ayurvedic medicines, with a business level of
about 20 million dollars annually. Its wide range of
Ayurvedic herbal formulations, covering most therapeutic
segments, was honored by the Indian government's
National Award for Quality Herbal Preparations and
National Award for R & D in the year 2002. It is known
for its proprietary formulas for hepatitis, diabetes,
menstrual disorders, digestive disorders, and urinary
diseases.
Several small companies that have grown rapidly in recent years envision themselves as primary
players in the Ayurvedic market. As an example, Viswakeerthy Ayurvedic Pharmacy promotes
itself as one of the largest suppliers of Ayurvedic medicines in India. It presents the following on
its website:
The market for Ayurvedic internal medicines is dominated by Chyawanprash, an herbal honey
comprised of about 3 dozen ingredients, with amla (emblic myrobalans) as the key ingredient.
The leader in this field is Dabur, which had a 69% market share at the end of 2002; followed by
Baidyanath, with nearly 11%, and Zandu and Himani (Emami Group) with about 7.5% each. A
variety of individual herbs, traditional formulations, and proprietary medicines make up the rest
of the health products section involving internal remedies, while the remainder of the market is
taken up by toothpastes and powders, skin creams, massage oils, shampoos, and other topical
preparations. Aside from Chyawanprash, the following are among the major traditional
remedies:
Rejuvenative tonic,
Triphala Terminalia chebula, Terminalia Belerica, harmonizer,
Three Myrobalans Emblica officinalis treatment for
intestinal disorders
Trikatu Piper longum, Zingiber officinale, Piper Spicy stimulant to
Three Pungents nigrum digestion
Two of the largest companies involved with providing traditional medicine products, such as the
above, are Himalaya Drug Company and Universal Medicaments (in Nagpur). Universal
Medicaments has a joint venture for research and manufacturing of herbal products with Cipla
Ltd. and Lupin Ltd, two leading pharmaceutical companies of India. Universal is engaged in
manufacturing and exports of both pharmaceutical formulations and research-based herbal
medicines.
Exports of Ayurvedic medicines have reached a value of 100 million dollars a year (about 10%
the value of the entire Ayurvedic industry in India). About 60% of this is crude herbs (to be
manufactured into products outside India), about 30% is finished product shipped abroad for
direct sales to consumers, and the remaining 10% is partially prepared products to be finished in
the foreign countries (see Appendix 1 for examples of Ayurvedic distribution from India with
products available worldwide).
The Indian government and non-government organizations have been collecting statistics on the
Ayurvedic system in India and these data about the manpower and institutional aspects of
Ayurveda have emerged:
Number of registered medical practitioners: 366,812
Number of dispensaries: 22,100
Number of hospitals: 2,189
Number of hospital beds: 33,145
Number of teaching institutions (undergraduate): 187
Number of upgraded postgraduate departments: 51
Number of specialties in postgraduate medical training: 16
Number of pharmacies manufacturing Ayurvedic medicines: 8,400
The SAARC (South Asia Association for Regional Cooperation) was formed in 1985; its
member countries are India, Pakistan, Nepal, Bangladesh, Bhutan, Maldives, and Sri Lanka.
These countries all have been influenced by Ayurvedic medicine. Trade in Ayurvedic medicines
within the SAARC is mostly limited to raw materials that grow in one region (e.g., high
mountains, northern climate) and are then exported to other regions (e.g., lowland southern
areas). Because of the large number of very small factories that try to service the local
communities, with products labeled with the local language, there is little opportunity for
suppliers in one SAARC country to send finished products to another SAARC or even abroad.
Entrepreneurs in these countries (mainly in India) seeking to break into the market for natural
products have determined, rightly, that the demand for traditional style Ayurvedic medicines
both inside and outside the region is limited, despite growth trends as high as 20% annually
encountered in the late 1990s. They have aimed to bolster interest by carrying out scientific
research into promising herbs and formulas that are based on Ayurveda but not necessarily
reflecting traditional practices. Of necessity, such research eventually focuses on finding of
active ingredients, and this has led to the development of isolates from plants that are sold as
"nutriceuticals" (substances not registered as drugs, but used like nutritional and dietary
supplements, sold over the counter in various formulations with specific health benefits
portrayed for them). For these, there is a growing worldwide demand. The main suppliers of
nutriceuticals are Japan, China, and the U.S., but India stands to become a significant
contributor.
Sabinsa produces extracts and special powders such as the following (uses are typical
applications sought by product manufacturers and may not reflect traditional Ayurvedic uses):
Hot Sip® (Combination of 4 herbs) combination of: Adhatoda cough & cold aid
Powdered Extract vasica, Alpinia galanga
Glycyrrhiza glabra, Piper
longum
As examples of how traditional Ayurvedic ingredients are converted to modern products, it has
been found that myrrh yields guggulsterones and frankincense yields boswellic acids that are
now in high demand. For both these herbs, the original research and product development
originated in India as part of an ongoing effort to investigate and make more useful the tradition
of Ayurvedic medicine. Much of the guggulsterone and boswellic acid currently used in
manufacturing products today comes from Sabinsa.
Guggulsterones are reputed to lower blood lipids, including cholesterol, a problem recognized
currently, but not an issue of traditional Ayurvedic medicine. The standardized nutriceutical
available for most manufacturing of products is 2.5% guggulsterones; preparations of 7.5% and
of 10% guggulsterones are produced, but the high sterone products are soft and more difficult to
use in manufacturing. The Sabinsa product is trademarked Gugulipid. Boswellic acids are
reputed to have potent anti-inflammatory activity, as demonstrated in laboratory experiments; its
traditional use would indicate an anti-inflammatory action. The standardized boswellic acid
preparations list their content as 50-70% boswellic acids, though it has been suggested that these
are actually total organic acids from frankincense, with boswellic acids as the major component.
The Sabinsa product is trademarked Boswellin.
This trend towards nutriceutical development has not been adopted by all. Some are still
interested in promoting the ancient tradition and sell the well-known prescriptions or make up
new proprietary formulas. An example of a company that sells complex Ayurvedic compounds is
Surya Herbal in New Delhi. They are the manufacturers and exporters of a wide range of
Ayurvedic generic, branded specialties and other OTC herbal healthcare products. The company
provides 15 formulations, which match, for the most part, the categories of natural therapeutics
in demand worldwide. The products include: Memory-Loss Capsules/Syrup; Mental Stress and
Fatigue Relieving Capsules; General Weakness Tonic for Men & Women; Liver Disorder
Curative Tablets/Syrup; Piles & Varicose Veins Tablets; Throat & Other Minor Infections
Therapy Tablets/Syrup; Menstrual Regulatory Capsules/Syrup; Cough Relief Tablets/Syrup; and
Constipation Regulatory Tablets/Syrup.
The biggest supplier of Ayurvedic herb products for the U.S. and other Western countries is
Maharishi Ayurveda Products International, Inc., currently located in Colorado. Despite its
dominance in the field, which came about because of the popularity of Maharishi Mahesh Yogi
in his teaching of transcendental meditation, the company still has only a limited market
presence and small staff. The Maharishi had attracted a few medical doctors to his program, and
they have been vocal proponents of the products, which is the reason for their continued use.
There are about two dozen products in their catalog.
In America, Europe, and other countries, it has long been recognized that it is difficult to
promote traditional medicine systems because of their complexity, so individual herbs become
the focus of attention. The main herb of interest from India is ashwaganda. It is not promoted as
much based on its role in Ayurveda, rather, it has been compared, with considerable hyperbole,
to ginseng, which was for many years the biggest selling medicinal herb on the international
market. So, it is called "Indian ginseng" by some (though to do so now in the U.S. is illegal) and
promoted as an "adaptogen," as a sexual tonic, and as an immune enhancer, but usually without
any reference to its characteristics as recognized by Ayurveda. It is included in formulations, but
mostly with non-Ayurvedic ingredients. Previously, the best promoted herb from Ayurveda was
Centella asiatica, one type of Brahmi. This herb became popular almost entirely on the basis of
one product (which contained two other non-Ayurvedic herbs), that was heavily promoted.
Confusion over the source led to substitution of a Chinese herb in most products recently.
However, this Ayurvedic herb is still promoted as an energizer (in Ayurvedic medicine it is a
sedative), and as a tonic for the brain (which is consistent with some Ayurvedic indications for
it).
There are serious problems with traditional Ayurvedic medicine in the West. In a separate article
(Status of Ayurveda in the U.S.), I have described significant barriers that exist to development of
the field here, where Chinese medicine has done fairly well. Visitors to India bring back
distressing stories about the status of Ayurvedic medicine education in India, which indicates
that there are problems arising in the source country.
Other issues influence the potential spread of Ayurvedic medicines. With the popularization of
herbal medicine in recent decades, along with the rapid growth in population, numerous species
used in making traditional formulas are becoming endangered. A good example is Nardostachys
(jatamansi), which is now permitted only in manufactured products and cannot be otherwise
exported; it is mainly obtained in Nepal. According to one estimate, 120 economically useful
plants in India are endangered, 35 of which are said to be important medicinals.
Quality control issues have come to the fore, with worries about contamination of plant products
by heavy metals, pesticides, and other substances, yet few Ayurvedic factories are large enough
and affluent enough to invest in the necessary testing procedures to demonstrate the quality of
the finished materials. The ones mentioned above, Surya and Universal, do have the capabilities
and produce certificates of analysis for their batches of product that reveal test data on
cleanliness and purity of the product.
September 2003
Note: The author would like to thank Lokesh Gupta, in Noida, India, for providing background
information relevant to the development of this article. Any inadvertent errors in representation
of the industry activities or its member companies are the sole responsibility of the current
author.
The development of international trade in Ayurvedic medicine came about at the same time that
the internet became a popular means of rapid communication. Most Ayurvedic suppliers provide
at least minimal contacts, and some provide extensive contacts, via the internet.
Follow this link for a sampling of 150 sites related to Ayurvedic medicine suppliers and
consultants on the internet (thanks to 123India.com).
Left: Some of the 500 Ayurvedic formulas developed by Arya Vaidya Sala; Right: Home of S. Varier, the
organization's founder.
Sri Varier, called the "savior of Ayurveda in the South" died in 1944. He had executed a will
prior to his demise, which converted his proprietary concern into a charitable trust of public
nature, to be run by a trust board consisting of seven members; as per the provisions of its
founder's will, Arya Vaidya Sala functions as a charitable trust.
Providing Ayruvedic health care services for tourists from around the world is one of the goals of
the modern Ayurvedic medicine industry. Although herb products can be shipped everywhere,
the services of Ayurveda-epitomized by the week-long Panch Karma regimen-are obtained by
staying at a special clinic. The Ayurvedic Natural Health Care Center is a group of sites in Goa
where people can visit for two weeks to experience a wide range of therapies. The Ayurvedic
system is particularly focused on cleansing (detoxifying) approaches, and uses numerous
methods for promoting elimination and relaxation, many of them involving application of
medicated oils.
A special technique aimed at providing relief for back pain using warm medicated oils or herbal
decoctions when bathing the lower back for 20 to 30 minutes.